C12N 2501/305
Growth hormone [gh], aka. somatotropin
Official title: Growth hormone [GH], aka. somatotropin
C12N2501/305 (Growth hormone [gh], aka. somatotropin) appears on 22 US grants and 49 published applications in this corpus.
Search patents in C12N- Granted patents
- 22
- Published applications
- 49
- Assignees
- 33
- Inventors
- 58
- Latest grant
- 7 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 1 |
| 2002 | 0 | 3 |
| 2003 | 0 | 1 |
| 2004 | 2 | 2 |
| 2005 | 0 | 3 |
| 2006 | 1 | 1 |
| 2007 | 0 | 3 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 2 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 2 |
| 2014 | 0 | 2 |
| 2015 | 0 | 0 |
| 2016 | 0 | 4 |
| 2017 | 0 | 2 |
| 2018 | 0 | 1 |
| 2019 | 0 | 2 |
| 2020 | 0 | 2 |
| 2021 | 2 | 3 |
| 2022 | 1 | 1 |
| 2023 | 3 | 5 |
| 2024 | 3 | 1 |
| 2025 | 3 | 3 |
| 2026 | 0 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Producing method of mesenchymal stem cell for prevention or treatment of brain neuronal disease including ghrelin treatment and use thereof7 Oct 2025US 12,433,935 B2Samsung Life Public Welfare Foundation
- Cancer-killing cells29 Jul 2025US 12,370,216 B2LIfT BioSciences Ltd
- Nucleoside modified mRNA and uses thereof29 Jul 2025US 12,371,666 B2Boston Medical Center Corporation
- Cancer-killing cells27 Aug 2024US 12,070,473 B2LIfT BioSciences Ltd
- Method to reproduce circadian rhythms on a microfluidic chip27 Feb 2024US 11,913,031 B2Yissum Research Development Company of the Hebrew University of Jerusalem
- Maturation medium compositions and methods for human heart organoid maturation17 Sep 2026US 2026/0275292 A1Board of Trustees of Michigan State University
- Cancer-killing cells23 Jul 2026US 2026/0207663 A2LIfT BioSciences Ltd
- Method for producing metabolically activated liver organoid, composition, and method for evaluating test substance2 Jul 2026US 2026/0185054 A1Jsr Corporation
- Producing method of mesenchymal stem cell for prevention or treatment of brain neuronal disease including ghrelin treatment and use thereof5 Mar 2026US 2026/0061034 A1Samsung Life Public Welfare Foundation
- Derivation of somatotrophs from stem cells and uses thereof11 Dec 2025US 2025/0376659 A1Memorial Sloan Kettering Cancer Center
Most cited
By later US patents
- Hepatic progenitors and method of isolating same43US 6,242,252 B1Albert Einstein College of Medicine of Yeshiva University · 2001
- Method of expanding hepatic precursor cells37US 5,576,207 AAlbert Einstein College of Medicine of Yeshiva University, a Division of Yeshiva University · 1996
- Culturing pancreatic stem cells having a specified, intermediate stage of development35US 6,759,039 B2AmCyte, Inc. · 2004
- Compositions comprising hepatocyte precursors21US 5,789,246 AAlbert Einstein College of Medicine · 1998
- Hapatoblasts and method of isolating same15US 6,069,005 AAlbert Einstein College of Medicine of Yeshwa University · 2000